Genomic arrays for the identification of high-risk chronic lymphocytic leukemia: ready for prime time?

por Cuneo, Antonio, Rigolin, Gian Matteo, Mecucci, Cristina
Publicado 2021

A Tangle of Genomic Aberrations Drives Multiple Myeloma and Correlates with Clinical Aggressiveness of the Disease: A Comprehensive Review from a Biological Perspective to Clinical...

por Sessa, Mariarosaria, Cavazzini, Francesco, Cavallari, Maurizio, Rigolin, Gian Matteo, Cuneo, Antonio
Publicado 2020

Right Atrium Mass Assessed with 18F-FDG PET/CT Scan Turns Out to Be an Uncommon Relapse of Testicular Diffuse Large B-cell Lymphoma: A Case Report

por Panareo, Stefano, Urso, Luca, Santi, Ivan, Rigolin, Gian Matteo, Cuneo, Antonio, Cittanti, Corrado, Bartolomei, Mirco
Publicado 2020

First-Line Treatment of Older Patients with CLL: A New Approach in the Chemo-Free Era

por Urso, Antonio, Cavazzini, Francesco, Ballardini, Maria Pia, Gambara, Silvia, Consolo, Sara, Rigolin, Gian Matteo, Cuneo, Antonio
Publicado 2023

Modern treatment in chronic lymphocytic leukemia: impact on survival and efficacy in high-risk subgroups

por Cuneo, Antonio, Cavazzini, Francesco, Ciccone, Maria, Daghia, Giulia, Sofritti, Olga, Saccenti, Elena, Negrini, Massimo, Rigolin, Gian Matteo
Publicado 2014

Old and New Drugs for Chronic Lymphocytic Leukemia: Lights and Shadows of Real-World Evidence

por Marchetti, Monia, Vitale, Candida, Rigolin, Gian Matteo, Vasile, Alessandra, Visentin, Andrea, Scarfò, Lydia, Coscia, Marta, Cuneo, Antonio
Publicado 2022

Metformin combined with sodium dichloroacetate promotes B leukemic cell death by suppressing anti-apoptotic protein Mcl-1

por Voltan, Rebecca, Rimondi, Erika, Melloni, Elisabetta, Gilli, Paola, Bertolasi, Valerio, Casciano, Fabio, Rigolin, Gian Matteo, Zauli, Giorgio, Secchiero, Paola
Publicado 2016

The γ-secretase inhibitors enhance the anti-leukemic activity of ibrutinib in B-CLL cells

por Secchiero, Paola, Voltan, Rebecca, Rimondi, Erika, Melloni, Elisabetta, Athanasakis, Emmanouil, Tisato, Veronica, Gallo, Stefania, Rigolin, Gian Matteo, Zauli, Giorgio
Publicado 2017

“Hemophagocytic Lymphohistiocytosis after EBV reactivation and ibrutinib treatment in relapsed/refractory Chronic Lymphocytic Leukemia”

por Cavallari, Maurizio, Ciccone, Maria, Falzoni, Simonetta, Cavazzini, Francesco, Formigaro, Luca, Di Virgilio, Francesco, Rotola, Antonella, Rigolin, Gian Matteo, Cuneo, Antonio
Publicado 2017

Sodium dichloroacetate exhibits anti-leukemic activity in B-chronic lymphocytic leukemia (B-CLL) and synergizes with the p53 activator Nutlin-3

por Agnoletto, Chiara, Melloni, Elisabetta, Casciano, Fabio, Rigolin, Gian Matteo, Rimondi, Erika, Celeghini, Claudio, Brunelli, Laura, Cuneo, Antonio, Secchiero, Paola, Zauli, Giorgio
Publicado 2014

The anti-leukemic activity of sodium dichloroacetate in p53(mutated/null) cells is mediated by a p53-independent ILF3/p21 pathway

por Agnoletto, Chiara, Brunelli, Laura, Melloni, Elisabetta, Pastorelli, Roberta, Casciano, Fabio, Rimondi, Erika, Rigolin, Gian Matteo, Cuneo, Antonio, Secchiero, Paola, Zauli, Giorgio
Publicado 2014

Ibrutinib synergizes with MDM-2 inhibitors in promoting cytotoxicity in B chronic lymphocytic leukemia

por Voltan, Rebecca, Rimondi, Erika, Melloni, Elisabetta, Rigolin, Gian Matteo, Casciano, Fabio, Arcidiacono, Maria Vittoria, Celeghini, Claudio, Cuneo, Antonio, Zauli, Giorgio, Secchiero, Paola
Publicado 2016

Response to Ibrutinib of a Refractory IgA Lymphoplasmacytic Lymphoma Carrying the MYD88 L265P Gene Mutation

por Quaglia, Francesca Maria, Rigolin, Gian Matteo, Saccenti, Elena, Negrini, Massimo, Volta, Eleonora, Dabusti, Melissa, Ciccone, Maria, Urso, Antonio, Laudisi, Michele, Cuneo, Antonio
Publicado 2019

Delirium in acute promyelocytic leukemia patients: two case reports

por Rigolin, Gian Matteo, Martinelli, Sara, Formigaro, Luca, Cibien, Francesca, Lista, Enrico, Cavallari, Maurizio, Ambrosio, Marco, Pizzolato, Miriam, Daghia, Giulia, Sofritti, Olga, Cuneo, Antonio
Publicado 2013

Overcoming of Microenvironment Protection on Primary Chronic Lymphocytic Leukemia Cells after Treatment with BTK and MDM2 Pharmacological Inhibitors

por Rimondi, Erika, Melloni, Elisabetta, Romani, Arianna, Tisato, Veronica, Casciano, Fabio, Rigolin, Gian Matteo, Milani, Daniela, Celeghini, Claudio, Zauli, Giorgio, Secchiero, Paola, Voltan, Rebecca
Publicado 2021

The p53 transcriptional pathway is preserved in ATM(mutated) and NOTCH1(mutated) chronic lymphocytic leukemias

por Athanasakis, Emmanouil, Melloni, Elisabetta, Rigolin, Gian Matteo, Agnoletto, Chiara, Voltan, Rebecca, Vozzi, Diego, Piscianz, Elisa, Segat, Ludovica, Dal Monego, Simeone, Cuneo, Antonio, Secchiero, Paola, Zauli, Giorgio
Publicado 2014

Hsa-miR-15a and Hsa-miR-16-1 Expression Is Not Related to Proliferation Centers Abundance and Other Prognostic Factors in Chronic Lymphocytic Leukemia

por Rossi, Maura, Fuligni, Fabio, Ciccone, Maria, Agostinelli, Claudio, Righi, Simona, Luciani, Marco, Laginestra, Maria Antonella, Rigolin, Gian Matteo, Sapienza, Maria Rosaria, Gazzola, Anna, Mannu, Claudia, Cuneo, Antonio, Pileri, Stefano, Piccaluga, Pier Paolo
Publicado 2013

Modulated expression of adhesion, migration and activation molecules may predict the degree of response in chronic lymphocytic leukemia patients treated with ibrutinib plus rituxim...

por Peragine, Nadia, De Propris, Maria Stefania, Intoppa, Stefania, Milani, Maria Laura, Mariglia, Paola, Mauro, Francesca Romana, Raponi, Sara, Soddu, Stefano, Cuneo, Antonio, Rigolin, Gian Matteo, Del Giudice, Ilaria, Foà, Robin, Guarini, Anna
Publicado 2020

Outcomes in patients with chronic lymphocytic leukemia and TP53 aberration who received first-line ibrutinib: a nationwide registry study from the Italian Medicines Agency

por Rigolin, Gian Matteo, Olimpieri, Pier Paolo, Summa, Valentina, Celant, Simone, Scarfò, Lydia, Tognolo, Lucia, Ballardini, Maria Pia, Urso, Antonio, Sessa, Mariarosaria, Gambara, Silvia, Cura, Francesca, Fortini, Monica, Ghia, Paolo, Cuneo, Antonio, Russo, Pierluigi
Publicado 2023

Employment of Oligodeoxynucleotide plus Interleukin-2 Improves Cytogenetic Analysis in Splenic Marginal Zone Lymphoma

por Bardi, Antonella, Cavazzini, Francesco, Rigolin, Gian Matteo, Tammiso, Elisa, Volta, Eleonora, Pezzolo, Elisa, Formigaro, Luca, Sofritti, Olga, Daghia, Giulia, Ambrosio, Cristina, Rizzotto, Lara, Abass, Awad E., D'Auria, Fiorella, Musto, Pellegrino, Cuneo, Antonio
Publicado 2011